Indicator Explainer
KMT2A Gene
This gene is involved in transcriptional regulation and alterations in the gene are associated with acute lymphoblastic leukemia.
This page explains what the indicator is and how results are interpreted in general terms. Reference ranges depend on the laboratory, the method, and your own situation — no single “normal value” applies to everyone. This page is health information, not a diagnosis. For symptoms, treatment, or urgent concerns, contact a healthcare professional.
When it is tested
Source: National Cancer Institute, NCI Thesaurus 26.09d, C18585. NCI definition, reproduced without modification under CC BY 4.0. Source identity and definition checked automatically on 2026-10-20. No individual clinical interpretation or human reviewer is asserted.
Reading results
Reference intervals and interpretation depend on the laboratory, specimen, method and clinical context. This source definition is educational information; it does not establish a diagnosis, product approval or suitability for an individual.
Also Known As
References
- NCI Thesaurus 26.09d — KMT2A Gene (C18585)
- Source: National Cancer Institute, NCI Thesaurus 26.09d, C18585. NCI definition, reproduced without modification under CC BY 4.0.
- [Clinical characteristics and prognosis of pediatric precursor lymphoid neoplasms with KMT2A gene rearrangement]. — Zhonghua Er Ke Za Zhi, 2026-08-01 (PMID 42527137; literature)
- [Combined analysis of epigenetic and transcriptomic data from children with Wiedemann-Steiner syndrome due to variants of KMT2A gene]. — Zhonghua Yi Xue Yi Chuan Xue Za Zhi, 2026-07-01 (PMID 42342635; literature)
- Clinical Characteristics of KMT2A Gene-Related Wiedemann-Steiner Syndrome and Progress in Recombinant Human Growth Hormone Therapy for Short-Stature Children. — Clin Endocrinol (Oxf), 2025-07-01 (PMID 40598692; literature)